Mosaic Biosciences: Biologics Brief
The science and strategy of making protein therapeutic medicines.
The Biologics Brief is a podcast about the science and strategy behind making protein therapeutic medicines. Hosted by the scientists at Mosaic Biosciences, a biologics discovery CRO, each episode unpacks the real decisions behind antibody discovery and biologics development, the same conversations we have with our partners every day.
From choosing the right discovery platform to evaluating a CRO, scoping a campaign, and navigating difficult targets, we get practical about what actually moves a program forward.
Whether you're building at an early-stage biotech, working in pharma, or just curious about how modern medicines get made, you'll come away with sharper questions to ask and frameworks worth keeping.
mosaicbio.com
Episodes
4 episodes
From Discovery to Drug: What Antibody Developability Really Means
In this episode of the Biologics Brief, Mosaic Biosciences' Chief Strategy Officer Tracey Mullen sits down with Stacy Capehart, Director of Data Sciences at Mosaic, to talk about what happens after you find a promising antibody, and why finding...
In Vivo Antibody Discovery with Humanized Transgenic Mice
In this episode of the Biologics Brief, Mosaic Biosciences' Chief Strategy Officer Tracey Mullen leads a conversation on in vivo antibody discovery using humanized transgenic mice. She's joined by Dan Rohrer (Chief Technology Officer, AbTherx),...
Single B Cell Discovery: Platforms, Trade-offs, and How to Actually Choose
Single B cell discovery has become one of the most powerful tools in antibody drug discovery, but with so many platforms on the market, how do you know which one is right for your campaign?In this special Spotlight episode of The Biologi...
How to Choose a CRO for Antibody Discovery
Your antibody program doesn’t fail because you picked the “wrong platform” as often as it fails because you picked the wrong partner. We get specific about how to choose a preclinical CRO for antibody discovery by starting with the one thing th...